New York, October 05, 2018: The global genome editing market is expected to grow at a CAGR of more than 14.0% between 2015 and 2023. The global genome Editing market is estimated to cross US$ 7.0 billion by the end of 2023.
The global genome editing market is rapidly increasing due to the increased government funding for genomics technology, rise in the production of genetically modified crops and technological advancements these all factors are driving the growth of this market.
Recent developments across genome editing technologies have resulted in the creation of next generation nucleases that have higher levels of accuracy when correcting genetic mutations and defects. The classes under the genome editing technologies are the 4 broad families of nucleases: ZFNs, TALENs, CRISPR/Cas9, and Meganucleases.
This market research report categorizes the genome editing market into the following segments:
The Genome Editing Market is Segmented on the lines of Technology, Application, End User and Geographical Region. By Technology this market is segmented on the basis of CRISPR/CAS9, TALENs, ZFNs, Antisense Technology and Other Technologies. By Application this market is segmented on the basis of Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering and Other Applications.
By End User this market is segmented on the basis of Biotechnology and Pharmaceutical Companies sector, Government and Academic Research Institutes sector and Other Research Organizations sectors. By Geographical Region this market is segmented on the basis of North America, Europe, Asia and Rest of the World.
Gene editing technologies have an impact across multiple applications areas including plant and animal genetic engineering. However, the area of most disruption is across human cell line engineering, which enables the development of next generation’s therapies and drugs. However, the agricultural industry has seen more success with gene editing techniques largely due to the less stringent regulatory environment.
Table of Contents
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Global Genome Editing/Engineering Market, By Technology
7 Global Genome Editing/Genome Engineering Market, By Application
8 Global Genome Editing/Engineering Market, By End User
8.2 Biotechnology & Pharmaceutical Companies
8.3 Academic & Government Research Institutes
8.4 Contract Research Organizations
9 Genome Editing/Genome Engineering Market, By Region
10 Competitive Landscape
11 Company Profiles
11.1 Thermo Fisher Scientific, Inc.
11.2 Merck KGaA
11.3 Horizon Discovery Group PLC
11.4 Genscript USA Inc.
11.5 Sangamo Biosciences, Inc.
11.6 Integrated DNA Technologies, Inc.
11.7 Lonza Group Ltd.
11.8 New England Biolabs, Inc.
11.9 Origene Technologies, Inc.
11.10 Transposagen Biopharmaceuticals, Inc.
Other Related Market Research Reports:
Company Name: Market Research Engine
Contact Person: John Bay
Country: United States
The post Global Genome Editing Market to Witness Steady Growth at 14.0% CAGR During appeared first on Herald Keeper.